NIBRT are looking to acquire an integrated platform for the manufacture of cell therapies. The ideal solution is one which allows for the processing of fresh or cryopreserved cells, including but not limited to total PBMC’s or selected or enriched T-cells, monocytes, or NK cells. The ideal solution is one which also allows for performing all aspects of the process, including cell washing, magnetic enrichment of specific populations, activation, viral transduction, transfection, expansion, cell culture and media exchange and formulation of the final cell product within the one instrument platform.
Deadline
The time limit for receipt of tenders was 2022-09-02.
The procurement was published on 2022-08-03.
Object Scope of the procurement
Title: An integrated system for cell therapy manufacture
PR22-026
Products/services: Laboratory, optical and precision equipments (excl. glasses)📦
Short description:
“NIBRT are looking to acquire an integrated platform for the manufacture of cell therapies. The ideal solution is one which allows for the processing of...”
Short description
NIBRT are looking to acquire an integrated platform for the manufacture of cell therapies. The ideal solution is one which allows for the processing of fresh or cryopreserved cells, including but not limited to total PBMC’s or selected or enriched T-cells, monocytes, or NK cells. The ideal solution is one which also allows for performing all aspects of the process, including cell washing, magnetic enrichment of specific populations, activation, viral transduction, transfection, expansion, cell culture and media exchange and formulation of the final cell product within the one instrument platform.
Show more
Estimated value excluding VAT: EUR 200 000 💰
1️⃣
Additional products/services: Laboratory, optical and precision equipments (excl. glasses)📦
Place of performance: Dublin🏙️
Main site or place of performance:
“National Institute For Bioprocessing Research and Training (NIBRT), Fosters Avenue, Mount Merrion, Blackrock, Co. Dublin”
Description of the procurement:
“NIBRT are looking to acquire an integrated platform for the manufacture of cell therapies. The ideal solution is one which allows for the processing of...”
Description of the procurement
NIBRT are looking to acquire an integrated platform for the manufacture of cell therapies. The ideal solution is one which allows for the processing of fresh or cryopreserved cells, including but not limited to total PBMC’s or selected or enriched T-cells, monocytes, or NK cells. The ideal solution is one which also allows for performing all aspects of the process, including cell washing, magnetic enrichment of specific populations, activation, viral transduction, transfection, expansion, cell culture and media exchange and formulation of the final cell product within the one instrument platform.
Show more Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
Scope of the procurement
Estimated total value excluding VAT: EUR 200 000 💰
Duration of the contract, framework agreement or dynamic purchasing system
The time frame below is expressed in number of months.
Description
Duration: 12
Legal, economic, financial and technical information Economic and financial standing
Selection criteria as stated in the procurement documents
Technical and professional ability
Selection criteria as stated in the procurement documents
Procedure Type of procedure
Open procedure
Administrative information
Time limit for receipt of tenders or requests to participate: 2022-09-02
16:00 📅
Languages in which tenders or requests to participate may be submitted: English 🗣️
Conditions for opening of tenders: 2022-09-02
16:00 📅
Complementary information Review body
Name: Nibrt
Postal address: Fosters Avenue
Postal town: Dublin
Postal code: A94 X099
Country: Ireland 🇮🇪
E-mail: karl.kelly@nibrt.ie📧
URL: www.nibrt.ie🌏
Source: OJS 2022/S 151-431701 (2022-08-03)